News

INOVIO Receives $71 Million Government Contract for Smart Device COVID-19 Vaccine

INOVIO Receives $71 Million Government Contract for Smart Device COVID-19 Vaccine

The U.S. Department of Defense granted the funding to INOVIO to support the large-scale manufacture of the company's proprietary CELLECTRA® 3PSP smart device and the procurement of CELLECTRA® 2000 devices. These devices are used to deliver COVID-19 vaccine candidate INO-4800 directly into the skin, prompting a strong immune response. Phase 1 clinical results are expected within 30 days, with Phase II/III anticipated in the summer. Yourway has the capacity to transport and deliver all clinical trial materials internationally.

Back to Index
Media

Upcoming Event

Clinical Operations in Oncology Trials East Coast 2020

July 15-16, 2020
Boston, MA, USA (Virtual)

Media

Articles

SUPPLY CHAIN SOLUTIONS – Storage and Distribution Support for Clinical Trials Worldwide

Open chat
Come chat with us!
Hello! How can I help you?